✦ LIBER ✦

N-Acetylaspartylglutamate is not demonstrated to be a selective mGlu3 receptor agonist

✍ Scribed by Edwin C. Johnson

Book ID: 111184675
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 97 KB
Volume: 119
Category: Article
ISSN: 0022-3042
DOI: 10.1111/j.1471-4159.2011.07480.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Double KO mice deficient in CPN and the

Double KO mice deficient in CPN and the anaphylatoxin receptors demonstrate that lethality due to acute complement activation is caused by C5a but not C3a

✍ Stacey Mueller-Ortiz; Dachun Wang; John Morales; Li Li; Jui-Yoa Chang; Rick Wets 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Process Development of a Scaleable Route

Process Development of a Scaleable Route to (2 R )-[3-(2-Aminopropyl)-1 H -indol-7-yloxy]- N,N -diethylacetamide: A Key Intermediate for AJ-9677, a Potent and Selective Human and Rat β 3 -Adrenergic Receptor Agonist

✍ Harada, Hiroshi; Fujii, Akihito; Odai, Osamu; Kato, Shiro 📂 Article 📅 2004 🏛 American Chemical Society 🌐 English ⚖ 124 KB

Discriminative stimulus properties of S3

Discriminative stimulus properties of S32504, a novel D3/D2receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox,N-desmethylclozapine, and by selective antagonists at dopamine D2but not D3receptors

✍ Mark J. Millan; Loretta Iob; Jean-Louis Péglion; Anne Dekeyne 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 345 KB

Characterization of [3H]-N-[R-(2- Benzot

Characterization of [3H]-N-[R-(2- Benzothiazolyl)thio-2-propyl]-2-chloroadenosine ([3H]-NNC 21-0136) binding to rat brain: Profile of a novel selective agonist for adenosine A1 receptors

✍ Christian Thomsen; Jacob S. Valsborg; Christian Foged; Lars Knutsen 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 389 KB 👁 2 views

## thio-2-propyl]-2-chloroadenosine (NNC 21-0136) is a novel adenosine agonist with neuroprotectant properties in rodent models of focal and global ischemia that exhibits diminished cardiovascular side effects when compared to reference A 1 agonists [Sheardown et al., 1995]. NNC 21-0136 is shown t

Correction to Structure–Activity Relatio

Correction to Structure–Activity Relationship Study of N 6 -(2-(4-(1 H -Indol-5-yl)piperazin-1-yl)ethyl)- N 6 -propyl-4,5,6,7-tetrahydrobenzo[ d ]thiazole-2,6-diamine Analogues: Development of Highly Selective D3 Dopamine Receptor Agonists along with a Highly Potent D2/D3 Agonist and Their Pharmacological Characterization

✍ Johnson, Mark; Antonio, Tamara; Reith, Maarten E. A.; Dutta, Aloke K. 📂 Article 📅 2013 🏛 American Chemical Society 🌐 English ⚖ 197 KB

MAGNA CARTAThe Great CharterPreamble

📂 Fiction 🌐 English ⚖ 11 KB 👁 18 views